From Prebiotics to Mitochondrial Response: A Critical Narrative Review of Microbiota-Host Metabolic Interactions and Their Implications for Child Neurodevelopment.

Abstract

Prebiotics can modify intestinal microbial fermentation and short-chain fatty acid (SCFA) production, but whether these changes improve mitochondrial bioenergetics or neurodevelopmental outcomes in children remains uncertain. This critical narrative review examines the relationships among prebiotic substrates, microbial metabolism, SCFA availability, host metabolic processing, mitochondrial function, and pediatric clinical outcomes. Literature was identified through PubMed/MEDLINE, journal and publisher websites, and citation tracking, with literature identification completed before October 15, 2026. Evidence was organized by intervention or exposure, biological system, and measured endpoint, distinguishing direct microbial metabolite exposure from oral prebiotic supplementation. Experimental studies show that butyrate supports oxidative energy metabolism in colonocytes and that mitochondrial responses to microbial metabolites vary with concentration, tissue, redox state, and individual metabolic capacity. Increased intestinal fermentation does not necessarily establish greater systemic metabolite availability, enhanced mitochondrial ATP synthesis, or improved neuronal function. Pediatric galactooligosaccharide trials have documented microbial changes without directly measuring mitochondrial ATP production or establishing consistent between-group improvements in behavioral or overall gastrointestinal outcomes. Findings from combined probiotic, prebiotic, and synbiotic interventions cannot establish prebiotic-specific efficacy. A hypothesis-generating framework termed fermentation-bioenergetic response uncoupling is proposed, comprising five potential points of divergence: substrate accessibility, microbial transformation, host exposure, metabolic processing, and mitochondrial functional response. Clinical outcomes are assessed separately. Missing downstream measurements indicate an evidence gap rather than demonstrated biological uncoupling. Future pediatric research should integrate chemically defined nutritional interventions, functional microbiome profiling, metabolomics, validated mitochondrial measurements, and prespecified clinically relevant outcomes. Current evidence does not establish prebiotics as treatments for mitochondrial dysfunction or core neurodevelopmental features; potential gastrointestinal benefits require evaluation for specific clinical indications.

Abstract as supplied by the indexing source. © the authors / publisher.